ABSTRACT -Genotoxicity of superparamagnetic iron-platinum (FePt) nanoparticles (NPs) capped with 2-aminoethanethiol (AET) was evaluated using the bacterial reverse mutation assay (Ames test) and in vitro chromosomal aberration test. Mutagenicity of AET-capped FePt NPs was found to be negative in the Ames test, while clastogenicity of FePt NPs seemed to be false-positive in the in vitro chromosomal in vitro genotoxicity tests, such as DNA adduct studies, are necessary to conclude that a positive aberration result is irrelevant.
INTRODUCTION
Iron-platinum (FePt) nanoparticles (NPs) are an excellent magnetic material for ultra-high density magnetic storage media because of their superior magnetic properties (Sun et al., 2000; Sun, 2006) . Meanwhile, FePt NPs are also expected to be a high-performance nanomagnet for magnetic medicine, such as magnetic hyperthermia (Maenosono and Saita, 2006) , magnetic resonance imaging (Zhao et al., 2001) , immunomagnetic cell separation (Gu et al., 2003) , and magnetofection (Dobson, 2006) , because it presents a high Curie temperature, high saturation magnetization and high chemical stability. However, to utilize FePt NPs in the field of medicine, their -ment safety of FePt NPs should also be investigated when they are utilized in device applications, such as hard-disk media. There is concern that nano-sized materials exhibit unknown biological or environmental effects, even if their bulk counterparts are known to be safe. Hence, it is an urgent issue to test the safety (or hazard) of nanomateet al., 2004; Hardman, 2006) . Recently, we investigated the mutagenicity of water-dispersible FePt NPs capped with tetramethylam--was found to be weakly positive, though the mutagenicity et al., 2007) . This result suggests that the mutagenicity is considered to In this study, the genotoxicity of FePt NPs capped with 2-aminoethanethiol (AET; aliases cysteamine, merAmes test (Wilcox et al. Salmonella typhimurium (S. typhimurium) TA98, TA100, TA1535 and TA1537, and Escherichia coli (E. coli) WP2uvrA , and by a chromosomal aberration test, using AET-capped FePt NPs have positive surface charge that is important for biological applications, and because AET are known to exhibit antimutagenic effects against chemical mutagens (Hartman and Shankel, 1990; Hoffmann et al., 1999) .
MATERIALS AND METHODS

Synthesis of FePt NPs
FePt NPs were synthesized using a previously report- ] (CAS registry number 17685-52-8; Sigma-Aldrich) was dissolved in 37.5 ml of hexane under a nitrogen atmosphere. Then, 0.72 ml of oleic acid (CAS registry number added to the solution. Meanwhile, 100 mg of platinum (II) 2 ] (CAS registry number 15170-57-7; Sigma-Aldrich), 0.87 ml of oleylamine (CAS registry number 112-90-3; Sigma-Aldrich), and 15 ml of diethylene glycol (CAS registry number 111-46-6; Sigma-Aldrich) were placed in a three-necked flask and the mixture was agitated for 5 min under an Ar atmosphere. Subsequently, the temperature was raised to 80°C. Then, the Fe 3 12 /hexane solution was rapidly inject-30 min at 80°C to remove volatile matter. Subsequently, -ing, FePt NPs capped with oleic acid were separated from the matrix by centrifugation. FePt NPs were characterized by transmission electron microscopy (TEM) and Xray diffractometry (XRD). The mean diameter, standard deviation of the size distribution, and crystal structure were found to be 3 nm ( Fig. 1 ), 14.5%, and face-centered cubic, respectively.
Ligand exchange
out following a method described in the literature (Tanaka and Maenosono, 2008) . Thirteen ml of chloroform (Kanto Kagaku) and 15.8 ml of methanol solution of AET hydrochloride (0.5 M; CAS registry number 156-57-0; Wako FePt NPs; then, the mixture was ultrasonically agitated for 10 min. After sonication, 15.8 ml of pure water was poured into the dispersion; then the dispersion was agitated for 5 min. Subsequently, the dispersion was centrifuged and the supernatant was then completely discarded. Finally, the precipitate was redispersed in pure water. As a consequence, we obtained an aqueous dispersion of AET-capped FePt NPs at a solid concentration of 5 wt% (stock dispersion). We prepared a 10 ml stock dispersion. Note that no aggregation was observed in the stock dispersion.
Ames test
The test was conducted according to standard procein this study were S. typhimurium TA98, TA100, TA1535, TA1537 and E. coli WP2uvrA , provided by the Japan Bioassay Research Center. Male rat liver S9 (Spraguewas purchased from Kikkoman Corp. (Chiba, Japan). S9 mix (1 ml) contained 0.1 ml of S9 fraction and 0.9 ml of Cofactor mix that contains Cofactor, MgCl 2 , KCl, Dphosphate. Thus, 1 ml of S9 mix contained 0.1 ml of S9, 8 μmol of MgCl 2 , 33 μmol of KCl, 5 μmol of D-glucoseand 100 μmol of sodium phosphate (pH 7.4). The mutagenicity test was conducted using a preincubation assay (Yahagi et al., 1977) . The tester strains were reaction mixture containing 0.1 M phosphate buffer/S9 mix (1 ml) and the AET-capped FePt NPs for 8 hr at 37°C. After incubation, top agar (100 ml) was added to the mixture, which was then poured onto a plate of minimal glucose agar medium. The plate was incubated for 48 hr at 37°C and revertant colonies that appeared were counted. Two plates were used for each dose and an average valmix was 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide (AF-2) for TA98 and TA100 strains, N-Ethyl-N'-nitro-N-nitrosoguanidine (ENNG) for the WP2uvrA strain, sodium azide (NaN 3 ) for the TA1535 strain, and 9-aminoacridine hydrochloride (9-AA) for the TA1537 strain. The positive control used during +S9 mix was 2-aminoanthracene (2-AA) for all tester strains.
In vitro chromosomal aberration test
The test was conducted according to standard proce-- Fig. 1 . TEM image of AET-capped FePt NPs with a mean diameter 3 nm. Vol. 34 No. 3 ka, Japan). The assay consisted of short-term and continuous (24 hr) treatments at three or more dose levels. The maximum dose of AET-capped FePt NPs was selected from the doses at which > 50% cell growth inhibition was observed in a preliminary test. For the short-term treatment, AET-capped FePt NPs were administered for 6 hr followed by a recovery period of 18 hr. For the metabolic activation, the cells were treated with the above-mentioned S9 mix (0.5 ml) together with FePt NPs (0.3 ml). Both with and without the metabolic activation system, and chromosome preparations were made using a standard air-dry method (Miyake et al., 2000) . The positive
The positive control used during +S9 mix was benzopyrene (BP). The frequency of the cells with structural and numeric chromosomal aberrations was scored in 100 well-spread metaphases for each dose. Types of structural chromatid and chromosome gaps (gap), fragmentation (frg), chromatid breaks (ctb), chromatid exchanges (cte), chromosome breaks (csb) and chromosome exchanges (cse) including dicentric and ring chromosomes. Polythe frequency of aberrant cells was < 5%, inconclusive
RESULTS AND DISCUSSION
Ames test
Aqueous dispersions of AET-capped FePt NPs were tested for bacterial mutagenicity using the S. typhimurium strains TA98, TA100, TA1535, TA1537, and the E. coli strain WP2uvrA . The concentrations of AET-capped FePt NPs used were 39.1 μg, 78.1 μg, 156 μg, 313 μg, 625 μg, 1,250 μg, 2,500 μg or 5,000 μg per plate. All experimental results are summarized in Table 1 . No growth inhibition was observed in any tester strains with or without S9 mix due to the addition of AET-capped FePt NPs, regardless of dose. The presence of precipitation of the NPs S9 mix. Mutagenicity was negative in all strains with or without S9 mix, as shown in Table 1 .
Recently, we investigated the mutagenicity of -capped FePt NPs was found to be weakly positive in the +S9mix +S9mix +S9mix +S9mix +S9mix 0 117 ± 6 130 ± 3 9 ± 3 9 ± 0 30 ± 1 40 ± 2 16 ± 0 29 ± 7 7 ± 0 10 ± 1 39.1 119 ± 3 123 ± 5 7 ± 1 7 ± 1 39 ± 4 35 ± 2 22 ± 2 25 ± 7 8 ± 3 12 ± 1 78.1 125 ± 5 124 ± 11 9 ± 1 8 ± 0 31 ± 6 37 ± 5 19 ± 4 22 ± 4 7 ± 1 11 ± 1 156 123 ± 5 119 ± 13 9 ± 2 8 ± 1 30 ± 1 35 ± 3 23 ± 4 31 ± 0 6 ± 0 8 ± 1 313 127 ± 9 120 ± 4 10 ± 1 7 ± 0 28 ± 1 40 ± 4 16 ± 1 24 ± 2 8 ± 1 10 ± 1 625 121 ± 7 121 ± 4 9 ± 3 9 ± 0 39 ± 1 30 ± 1 20 ± 1 22 ± 5 7 ± 1 12 ± 1 1250 117 ± 8 136 ± 8 13 ± 0 8 ± 3 38 ± 4 39 ± 1 18 ± 0 24 ± 5 6 ± 1 9 ± 1 2500 154 ± 16 129 ± 1 10 ± 3 12 ± 1 34 ± 3 34 ± 3 21 ± 4 29 ± 4 6 ± 1 10 ± 3 5000 150 ± 4 128 ± 4 13 ± 0 15 ± 2 40 ± 3 43 ± 4 19 ± 1 29 ± 4 8 ± 2 10 ± 0
Positive 950 ± 35 864 ± 30 434 ± 12 308 ± 16 632 ± 29 757 ± 82 557 ± 12 434 ± 7 311 ± 98 134 ± 12 (0.01) (1.0) (0.5) (2.0) (2.0) (10) (0.1) (0.5) (80) (2.0)
ENNG for the WP2uvrA strain, NaN 3 for the TA1535 strain, and 9-AA for the TA1537 strain; during +S9 mix 2-AA was used for all tester strains. Values in parentheses correspond to the doses of positive control chemicals (μg/plate).
TA100 strain without S9 mix, though the mutageniciet al.,
FePt NPs was negative in the present study as mentioned above. The antimutagenicity of AET has been shown in combination with several chemical mutagens (Hartman and Shankel, 1990; Hoffmann et al., 1999) . Hoffmann et al. (1999) studied the protective effects of AET against -et al., 1999) . They found that two fundamentally different mechanisms of antimutageniciby a nucleophilic antimutagen and depletion of molecuFe sites on the FePt NP surfaces and stabilize NPs. In the case of AET, however, Pt sites on the NP surfaces are selectively covered with AET due to the strong Pt-thiol interaction ( Fig. 2) (Tanaka and Maenosono, 2008) . Pt is known to be an excellent catalyst for oxygen reduction. In addition, catalytic activity of FePt NPs for the preferential compared to that of Pt NPs, because of a noncompetitive dual site mechanism (Yin et al., 2008) . It means that platinum site in Pt 0 x or Fe 0 2 dissociative-adsorption site enhances the surface reaction between the reactants on the neighboring sites. Hence, the results suggest that some catalytic effects of FePt NPs might be responsible for the mutagenicity of bare FePt NPs, and AET effectively block the mutagenic activity of FePt NPs via selective adsorption on Pt sites. Alternatively, AET molecules desorped from the surfaces of FePt NPs may exert the protective effects against the genotoxicity of bare FePt NPs.
In vitro chromosomal aberration test
The results of the in vitro chromosomal aberration test of AET-capped FePt NPs are shown in Table 2 . In the 24-hr continuous treatment without S9 mix, FePt NPs caused -(6-27% of aberrant cells). Cytotoxicity of over 50% in the term treatments with and without S9 mix, it was negative -er, clear increases in the frequencies of cells with chroof aberrant cells) for +S9 mix, and at the dose range of
The majority of the aberrations were chromatid breaks and chromatid exchanges ( Table 2 ). The results suggest -mal aberration frequencies are seen at levels of cytotoxicity slightly less than 50% in all cases as shown in Table 2 . It is widely accepted that chromosomal aberrations can be formed as an indirect consequence of high levels of cell killing (Kirkland, 1992; Hilliard et al., 1998) . Therefore, clastogenicity of AET-capped FePt NPs may be false-positive. At the present stage, a comparative discussion is dif--ty of FePt NPs to the best of our knowledge.
In conclusion, mutagenicity of AET-capped FePt NPs was found to be negative in the Ames test, while clastogenicity of AET-capped FePt NPs seemed to be falsepositive in the in vitro chromosomal aberration test using in vitro genotoxicity tests, such as DNA adduct studies, are necessary to conclude that a positive aberration result is irrelevant. Fig. 2 . Vol. 34 No. 3 
